During the past decade, Mercy Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Research Institute" #1 sponsor was "Pfizer" with 3 trials, followed by "Angel Medical Systems" with 1 trials sponsored, "Columbia University" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Research Institute" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "Symbios Clinical" with 1 trials as a collaborator, "Tragara Pharmaceuticals, Inc." with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Research Institute" are "Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction (AMI)" (1 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials) and "Coronary Occlusion" (1 trials). Many other conditions were trialed in "Mercy Research Institute" in a lesser frequency.

Most popular intervention types in "Mercy Research Institute" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Docetaxel or Pemetrexed" (1 trials), "Guardian System" (1 trials), "Inotuzumab ozogamicin" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Research Institute" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mercy Research Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Research Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".